CTC (Chicago Trading Company)
NVAX icon

CTC (Chicago Trading Company)’s Novavax NVAX Stock Holding History

CTC (Chicago Trading Company)’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-85
Closed -$40.8K – 331
2023
Q4 		$40.8K Sell
85
-219
-72% -$1.34K ﹤0.01% 307
2023
Q3 		$220K Sell
304
-223
-42% -$1.78K ﹤0.01% 327
2023
Q2 		$392K Sell
527
-2,992
-85% -$23.5K ﹤0.01% 302
2023
Q1 		$2.32M Buy
3,519
+1,159
+49% +$10.7K ﹤0.01% 304
2022
Q4 		$2.42M Sell
2,360
-1,019
-30% -$18K ﹤0.01% 273
2022
Q3 		$6.12M Buy
3,379
+401
+13% +$17.4K ﹤0.01% 256
2022
Q2 		$15.3M Sell
2,978
-536
-15% -$27.8K 0.01% 217
2022
Q1 		$25.8M Buy
3,514
+8
+0.2% +$713 0.01% 201
2021
Q4 		$50.1M Buy
3,506
+328
+10% +$56.4K 0.02% 100
2021
Q3 		$65.8M Buy
+3,178
New +$700K 0.03% 76

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

CTC (Chicago Trading Company)'s NVAX Position: Q2 2022 in Review

CTC (Chicago Trading Company) sold out of Novavax (NVAX) in Q2 2022, closing a stake of 10,983 shares — an estimated $569K sold.

CTC (Chicago Trading Company) first reported a position in NVAX in Q3 2021 and held it in 3 quarters. The position peaked at $37.1M in Q3 2021. 326 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • CTC (Chicago Trading Company) reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 10,983 Novavax shares in Q2 2022, an estimated $569K.
  • CTC (Chicago Trading Company) first reported a position in Novavax in Q3 2021 and held it in 3 quarters.
  • CTC (Chicago Trading Company)'s Novavax position peaked at $37.1M in Q3 2021.
  • 326 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on CTC (Chicago Trading Company)'s 13F filing for Q2 2022, filed 7 Jul 2022.